Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
130.9 USD | -0.65% | +0.64% | +20.23% |
May. 15 | Merck to present new oncology data | CF |
May. 14 | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.23% | 334B | |
+33.13% | 709B | |
+30.77% | 595B | |
-2.23% | 367B | |
+4.95% | 289B | |
+14.23% | 239B | |
+9.03% | 211B | |
-3.44% | 203B | |
+8.57% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Co. Insider Sold Shares Worth $1,845,083, According to a Recent SEC Filing